On June 15, 2026, AnaptysBio, Inc. entered into a 12-month sublease agreement with First Tracks Biotherapeutics, Inc. for approximately 45,057 rentable square feet of space in San Diego, California. The sublease term commences on June 15, 2026, and includes a renewal option for First Tracks to extend the term until April 4, 2028. AnaptysBio, Inc. is a biotechnology company focused on developing therapeutic solutions.